DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Pharmaceutical Capex Project Reporting Package - Belgium" report to their offering.
This Pharmaceutical capex project reporting extends throughout Belgium and covers all aspects of capital investment in product development and manufacturing across the industry, including primary, secondary, biotech, OTC, medical devices and personal care products.
Projects included within the package are all scheduled to enter the Procurement Phase during 2016 and range from plant upgrades and modifications to expansions and complete new builds, all with a breadth of scope to include a wide range of process equipment and associated services. The package's focus on the processing aspects of projects also includes the production environment and ancillary services such as cleanrooms, HVAC, utilities, effluent treatment and laboratories.
One of the most important features of this project reporting is the inclusion of key decision makers which includes contacts with roles encompassing:
- External consultants
- Technology providers
- Design
- Engineering
- EPC contractors
- Equipment specification & selection
- Procurement
- Planning
- Project management
- Operations management
Within this package there are 64 project reports which include:
- Capital Expenditure > 1m
- Scheduled to enter procurement phase during 2016
- Project Types:
- - New Builds
- - Expansions
- - Upgrades
- - Modifications
- Facility Types
- - Manufacturing Processes
- - Product Development / R&D
- - Controlled Storage
- - Site Utilities
Key Topics Covered:
The following information is provided for each project:
1. Company Information
- Name
- Address
- Phone
- Web Site
2. Project Information
- Sensitivity
- Description
- Product Type
- Project Location
- Project Region
- Value
- Status
3. Contacts
4. Schedule
5. Notes
- Background
- Project
- Project Scope
Companies Mentioned
- Ablynx NV
- Baxalta Belgium sprl
- CAF-DCF CVBA
- Capsugel Belgium NV
- Cenexi - Laboratoires Thissen SA
- Centre Spécialités Pharmaceutiques SA
- Datwyler Pharma Packaging Belgium NV
- Euroscreen SA
- Firmenich Belgium SA
- Genencor International Belgium BVBA
- Genzyme Geel BVBA
- GlaxoSmithKline Biologicals
- Janssen Pharmaceutica NV
- L'Oreal Libramont SA
- Laboratoria Smeets NV
- Lonza Verviers Sprl
- MSD Animal Health
- Medgenix Benelux NV
- Metagenics Belgium bvba
- Milcobel CVBA
- Novasep SAS
- Odyssea Pharma sprl
- Pfizer Manufacturing Belgium NV
- Schering-Plough Labo NV
- UCB Pharma SA
- Zoetis Belgium SA
For more information visit http://www.researchandmarkets.com/research/c3vq27/pharmaceutical
